A Phase II Study of TPEx (Taxotere-platinum-cetuximab) Followed by a Maintenance With Avelumab and Cetuximab in First Line Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (TATIANA)
Latest Information Update: 21 Jan 2025
At a glance
Most Recent Events
- 15 Jan 2025 Status changed from not yet recruiting to recruiting.
- 17 Oct 2024 New trial record